BioSpace News Archive

SAN FRANCISCO, Feb. 12, 2020 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc. (Nasdaq: VIR), a clinical-stage immunology company focused on immune approaches to treating and preventing serious infectious diseases, today announced that it has identified two monoclonal antibodies (mAbs) that bind to SARS-CoV-2 (previously known as “2019-nCoV”), which were originally found because they bind and neutralize the original SARS-CoV. The antibodies target the SARS-CoV-2 spike protein in the region that the

IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), a leading global provider of advanced analytics, technology solutions, and contract research services to the life sciences industry, today reported financial results for the quarter and year ended December 31, 2019.

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today reported results for the year and the quarter ended December 31, 2019.

Daxor Corporation(NYSE MKT: DXR) an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume measurement today announces it will be attending the Society for Critical Care Medicine (SCCM) 49th Congress at the Orlando Convention Center in Orlando, FL, from February 16-18th, 2019.

XRHealth, formerly known as VRHealth, the leader in extended reality and therapeutic applications, today announced the first virtual reality telehealth clinic that will provide VR therapy to patients.

SOUTH SAN FRANCISCO, Calif. , Feb. 12, 2020 /PRNewswire/ -- Portola Pharmaceuticals, Inc. ® (NASDAQ: PTLA) today announced that it will host a webcast and conference call to discuss the Company’s financial results for the fourth quarter and full year ended December 31, 2019 , and provide a general business overview, on Wednesday, February 26, 2020, at 4:30 p.m. ET ( 1:30 p.m

Feb. 12, 2020 13:00 UTC -Dr. Scott C. Brun joins Axial Board to support the advancement of the Company’s Autism and Parkinson’s Programs- WALTHAM, Mass.--( BUSINESS WIRE )-- Axial Biotherapeutics, a biotechnology company dedicated to building a unique class of gut-targeted programs for neurodegenerative diseases and neurodevelopmental disorders, today announced the appointment of Scott Brun M.D. to its Board of Directors. In addition, the Company announced the promotions an

Feb. 12, 2020 13:00 UTC SAN FRANCISCO, Calif.--( BUSINESS WIRE )-- Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced it has received ISO 27001:2013 certification for its Information Security Management System (ISMS). ISO 27001:2013 is an information security standard published by the International Organization for Standardization (ISO), the world’s

LONDON and CARLSBAD, Calif., Feb. 12, 2020 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (Nasdaq: GWPH, “GW” or “the Company”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, will announce on February 25th, 2020 its financial results for the fourth quarter and year ending December 31st, 2019. GW will also host a conference call the same day at 4:30 p.m. ET. Conference call information will be

Perricone MD, the brand that continuously seeks to unlock the powerful science behind healthy-looking skin, announces the launch of Cold Plasma Plus+ Sub-D/Neck, an enhanced iteration of the brand’s number one best-selling product - adored by celebrities, dermatologists, aestheticians and skincare enthusiasts alike.